Navigation Links
Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
Date:2/21/2012

STOCKHOLM, February 21, 2012 /PRNewswire/ --

Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.

Cadila Pharmaceuticals will sell the entire line of Bactiguard´s products throughout India. The Indian medical device market is currently worth approximately 2 billion US dollar and growing 15% annually.

"For Bactiguard this is a milestone. India is one of the world's most interesting and fastest growing markets right now, and we are proud to be able to help India with our expertise in the field of infection protection. We are hoping to reduce the number of hospital acquired infections and thereby also reduce the use of antibiotics in India together with Cadila. I am very proud to be able to work with Cadila to improve health care in India", says Christian Kinch, CEO of Bactiguard.

Dr. Rajiv I. Modi, Managing Director, Cadila Pharmaceuticals Ltd. has explained why Cadila has chosen to work with Bactiguard. "We have chosen to work with Bactiguard of Sweden because hospital- acquired infections are a big problem for patients in our country and Bactiguard has a unique solution targeted at preventing health care associated infections. We are confident that hospitals in our country will embrace Bactiguard's clinically proven solution in order to help save lives in India."

This co-operation between Cadila Pharmaceuticals and Bactiguard was facilitated by Dr.C.B. Sanjeevi of Karolinska Institute and Invest Sweden assisted together. Another important role was played by the Swedish EKN, Export Credit Guarantee Authority to make the exclusive agreement.

Photo text: Dr. Rajiv I. Modi, Managing Director, Cadila Pharmaceuticals Ltd together with
Mr Christian Kinch, CEO, Bactiguard

Bactiguard provides world-leading solutions preventing hospital-acquired infections - the 4th largest cause of death in the western world. By using Bactiguard technology Governments can reduce healthcare cost, lower the use of antibiotics and save lives. The Bactiguard technology consists of an extremely thin noble metal coating, with antimicrobial and biocompatible properties that can be used on all sorts of medical devices. The Bactiguard coated urinary catheter has since 1995 been used by more than 110 million patients in the US. Today Bactiguard offers a full range portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.

Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last six decades, it has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over 90 other countries across the world. An integrated healthcare solutions provider with pharmaceutical product basket, it caters to over 45 therapeutic areas that include cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.

http://www.bactiguard.com


'/>"/>
SOURCE Bactiguard
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation
2. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
3. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
4. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
5. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
6. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
7. UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
8. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
9. Verify Brand™ Announces the Release of VB Enterprise 4.0
10. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
11. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):